Thomas Bender - Cooper Companies Independent Chairman of the Board
COO Stock | USD 88.84 1.09 1.21% |
Chairman
Mr. A. Thomas Bender is Independent Chairman of the Board of Cooper Companies Inc. He also served as our President and Chief Executive Officer from May 1995 until his retirement in October 2007. He previously served as President of CooperVision, our contact lens subsidiary, from June 1991 to December 2004. Between 1966 and June 1991, Mr. Bender held a variety of management positions at Allergan, Inc., a manufacturer of eye and skin care products, including Corporationrationrate Senior Vice President, and President and Chief Operating Officer of Herbert Laboratories, Allergans dermatology division. Mr. Bender serves on the board of directors of Allegro Ophthalmics LLC, a private ophthalmic company focused on pharmaceutical treatment of eye disease. Mr. Bender currently serves on the compensation and audit committees at Allegro. He also serves on the board of Mission Hospital Foundation in Mission Viejo, CA. since 2007.
Age | 78 |
Tenure | 17 years |
Phone | 925 460 3600 |
Web | https://www.coopercos.com |
Cooper Companies Management Efficiency
The company has Return on Asset of 0.0269 % which means that on every $100 spent on assets, it made $0.0269 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0387 %, implying that it generated $0.0387 on every 100 dollars invested. Cooper Companies' management efficiency ratios could be used to measure how well Cooper Companies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | CHAIRMAN Age | ||
Fred Lampropoulos | Merit Medical Systems | 74 | |
King Harris | AptarGroup | 73 | |
Vivek Jain | ICU Medical | 52 | |
Stephen MacMillan | Hologic | 60 | |
Alexander Rich | Repligen | 86 | |
Patrick Zenner | West Pharmaceutical Services | 73 | |
Ronald Gelbman | Haemonetics | 70 | |
Benson Smith | Teleflex Incorporated | 71 | |
Brenton JD | Bausch Lomb Corp | 54 | |
Howard Donnelly | AngioDynamics | 56 | |
Vincent Forlenza | Becton Dickinson and | 66 | |
Ellen Zane | Haemonetics | 69 | |
Thomas Polen | Becton Dickinson and | 51 | |
Peter Farrell | ResMed Inc | 78 | |
Liam Kelly | Teleflex Incorporated | 57 | |
Richard Meelia | Haemonetics | 71 | |
Jay Stein | Hologic | 72 | |
George Fotiades | AptarGroup | 67 |
Management Performance
Return On Equity | 0.0387 | ||||
Return On Asset | 0.0269 |
Cooper Companies Leadership Team
Elected by the shareholders, the Cooper Companies' board of directors comprises two types of representatives: Cooper Companies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cooper. The board's role is to monitor Cooper Companies' management team and ensure that shareholders' interests are well served. Cooper Companies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cooper Companies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Weiss, CEO and President Non-Independent Director and Member of Science and Technology Committee | ||
Carol Kaufman, Chief Admin. Officer, Chief Governance Officer, Executive VP and Secretary | ||
Teresa Madden, Independent Director | ||
Holly Sheffield, Executive Vice President and Chief Strategy Officer | ||
Kim Duncan, Senior Director - Investor Relations | ||
Agostino Ricupati, Senior Vice President - Finance and Tax, Chief Accounting Officer | ||
Mark Drury, Vice President General Counsel, Secretary | ||
Gerard III, I CooperVision | ||
A Bender, Independent Chairman of the Board | ||
Daniel McBride, Chief Operating Officer, Executive Vice President, President of CooperVision, Inc. | ||
Thomas Bender, Independent Chairman of the Board | ||
Tina Maloney, Principal Accounting Officer and Corporate Controller | ||
Paul Remmell, President and CEO of CooperSurgical Inc. | ||
Maria Rivas, Independent Director | ||
Albert White, President, Chief Executive Officer, Director | ||
Juan Aragon, Pres Division | ||
Albert III, CEO President | ||
Allan Rubenstein, Independent Vice Chairman of the Board, Lead Director | ||
Donald Press, Independent Director | ||
Stanley Zinberg, Independent Director | ||
Steven Rosenberg, Independent Director | ||
William Kozy, Lead Independent Director | ||
Randal Golden, Vice President, General Counsel, Secretary | ||
Robert Auerbach, President - CooperSurgical | ||
Warner H, President CooperVision, Inc | ||
Gary Petersmeyer, Independent Director | ||
Gregory Matz, CFO, Chief Risk Officer and Sr. VP | ||
Daniel Esq, Executive COO | ||
Jody Lindell, Independent Director | ||
Colleen Jay, Independent Director | ||
Nicholas Khadder, General Secretary | ||
Michael Kalkstein, Independent Director | ||
Brian Andrews, Chief Financial Officer, Executive Vice President, Treasurer |
Cooper Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cooper Companies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0387 | ||||
Return On Asset | 0.0269 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 20.58 B | ||||
Shares Outstanding | 198.76 M | ||||
Shares Owned By Insiders | 0.54 % | ||||
Shares Owned By Institutions | 99.46 % | ||||
Number Of Shares Shorted | 2.15 M | ||||
Price To Earning | 35.89 X |
Pair Trading with Cooper Companies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cooper Companies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cooper Companies will appreciate offsetting losses from the drop in the long position's value.Moving together with Cooper Stock
0.81 | CAH | Cardinal Health Earnings Call This Week | PairCorr |
0.66 | CVS | CVS Health Corp Financial Report 1st of May 2024 | PairCorr |
0.66 | DHR | Danaher | PairCorr |
Moving against Cooper Stock
0.52 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
0.45 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Cooper Companies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cooper Companies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cooper Companies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Cooper Companies to buy it.
The correlation of Cooper Companies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cooper Companies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cooper Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cooper Companies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in The Cooper Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Cooper Stock analysis
When running Cooper Companies' price analysis, check to measure Cooper Companies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cooper Companies is operating at the current time. Most of Cooper Companies' value examination focuses on studying past and present price action to predict the probability of Cooper Companies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cooper Companies' price. Additionally, you may evaluate how the addition of Cooper Companies to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Cooper Companies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cooper Companies. If investors know Cooper will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cooper Companies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cooper Companies is measured differently than its book value, which is the value of Cooper that is recorded on the company's balance sheet. Investors also form their own opinion of Cooper Companies' value that differs from its market value or its book value, called intrinsic value, which is Cooper Companies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cooper Companies' market value can be influenced by many factors that don't directly affect Cooper Companies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cooper Companies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cooper Companies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cooper Companies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.